| International Society for the Study of Fatty Acids & Lipids |
 |
7th Congress of the ISSFAL, 23 – 28 July 2006
incorporating the, 6th International Congress on Essential Fatty Acids and Eicosanoids
& PUFA in Maternal and Infant Health, 2006 Annual Scientific Meetings Cairns Convention Centre, Cairns, Queensland |
| [Home page]
[Latest News]
[Overview & History]
[Cairns]
[Optional Tours]
[Program]
[Invited Speakers]
[Abstract Submission & Funding]
[Registration & Accommodation]
[Exhibition & Sponsorship]
[Email registration of interest]
[Site map] |
Site map
- Home page
- Conference Postcard [PDF]
- Unilever workshop on polyunsaturated fatty acids and child cognition
28 July, 2006 [PDF]
- Omega-3 Research Institute Inc. Satellite Symposium
Omega-3 Fatty Acids in Type 2 Diabetes Mellitus: An Update
Sunday 23 July 2006, 8:00 am-1:00 pm [PDF]
- Current Program - Controversies and Consensus
(as at 17 July 2006) [PDF]
- Latest News
- Overview & History
- Cairns
- Optional Tours
- Program
- Invited Speakers
- DOCOSAHEXAENOIC ACID SIGNALING IN AGING, STROKE AND ALZHEIMERS DISEASE [PDF]
- FATTY ACID ABNORMALITIES IN ATOPIC DISEASE: EVIDENCE EXAMINED AND ROLE IN THE DISEASE PROCESS EXPLORED [PDF]
- ANTIOXIDANTS - DO THEY DO ANYTHING? [PDF]
- IMPACT OF MODEST OMEGA-3 FATTY ACID SUPPLEMENTATION ON MURINE INFECTIOUS DISEASE RESISTANCE AND HEPATIC GENE PROFILES [PDF]
- LIPID MEDIATORS IN INFLAMMATORY RESOLUTION; NEW PERSPECTIVES ON THE INFLAMMATORY RESPONSE AND AN EMERGING ERA IN ANTI-INFLAMMATORY DRUG DEVELOPMENT [PDF]
- INCREASED SUPPLY OF LC-PUFA THROUGH PLANT BIOTECHNOLOGY [PDF]
- POLYUNSATURATED FATTY ACIDS IN THE PATHOGENESIS AND TREATMENT OF MULTIPLE SCLEROSIS [PDF]
- MEMBRANE FATTY ACIDS AS PACEMAKERS OF ANIMAL METABOLISM [PDF]
- BIOACTIVE LIPIDS AND THEIR NUTRIENT INTERACTIONS. [PDF]
- COX-2 INHIBITORS: BIOLOGY, ETHICS, LAW [PDF]
- A TALE OF OMEGA-3: FROM FAT TO FAT-1 [PDF]
- NEUROTROPHIC EFFECTS OF DOCOSAHEXAENOIC ACID; MECHANISTIC INVESTIGATION [PDF]
- OMEGA 3 PUFA & THE METABOLIC SYNDROME [PDF]
- SYSTEMATIC REVIEWS AND LARGE SCALE RANDOMISED CONTROLLED TRIALS: WE’VE COME A LONG WAY BABY! [PDF]
- COMMUNICATING RISKS AND BENEFITS OF DIETARY FATS: BEYOND SAFETY SCARES [PDF]
- PRENATAL FATTY ACID EXPOSURE AND EARLY IMMUNE DEVELOPMENT [PDF]
- HIGH BLOOD CHOLESTEROL AS PREDICTOR FOR LOW CANCER MORTALITY AND LONGEVITY [PDF]
- DIETARY FATS AND LONGEVITY [PDF]
- WHAT ARE THE NORMAL RATES OF HUMAN BRAIN METABOLISM OF ARACHIDONIC AND DOCOSAHEXAENOIC ACIDS, AND WHAT MAY HAPPEN WHEN THEIR METABOLIC BALANCE IS ALTERED BY DIETARY N-3 PUFA DEPRIVATION? [PDF]
- n-3 FATTY ACIDS, MORTALITY AND CORONARY HEART DISEASE: EVIDENCE FROM RANDOMISED CONTROLLED TRIALS [PDF]
- Abstract Submission & Funding
- Registration & Accommodation
- Registration Brochure [PDF]
- Exhibition & Sponsorship
- List of exhibitors and sponsors [PDF]
- Email registration of interest
|
| |
|